JP2665850B2
(ja)
*
|
1991-11-14 |
1997-10-22 |
塩野義製薬株式会社 |
hBNPのC端を認識するモノクロ−ナル抗体
|
PT2292662E
(pt)
|
1996-03-04 |
2014-07-16 |
Scios Inc |
Ensaio e reagentes para a quantificação de hbnp
|
WO1999022235A1
(fr)
|
1997-10-24 |
1999-05-06 |
Shionogi & Co., Ltd. |
Procede d'inhibition de la decomposition de peptides natriuretiques et procede ameliore de dosage de peptides natriuretiques a l'aide desdits peptides
|
US7226729B1
(en)
|
1997-04-01 |
2007-06-05 |
Shionogi & Co., Ltd. |
Method for inhibiting degradation of brain natriuretic peptides
|
JP3516655B2
(ja)
*
|
1997-09-11 |
2004-04-05 |
塩野義製薬株式会社 |
Bnpの免疫測定法
|
US6117644A
(en)
*
|
1998-06-04 |
2000-09-12 |
Ottawa Heart Institute Research Corporation |
Predicting and detecting cardiac allograft rejection
|
US6083700A
(en)
*
|
1998-06-26 |
2000-07-04 |
Incyte Pharmaceuticals, Inc. |
Human goose-type lysozyme
|
AT407674B
(de)
*
|
1998-09-29 |
2001-05-25 |
Biomedica Gmbh |
Verfahren zur bestimmung von atrialem natriuretischem peptid (anp)
|
GB9827348D0
(en)
*
|
1998-12-12 |
1999-02-03 |
Univ Leicester |
Natriuretic peptide
|
ATE403158T1
(de)
*
|
1999-01-29 |
2008-08-15 |
Roche Diagnostics Gmbh |
Verfahren zum nachweis von n-terminalem probnp
|
WO2002038794A2
(en)
|
2000-11-09 |
2002-05-16 |
The Brigham And Women's Hospital, Inc. |
Cardiovascular disease diagnostic and therapeutic targets
|
US7632647B2
(en)
*
|
2001-04-13 |
2009-12-15 |
Biosite Incorporated |
Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
|
US20030199000A1
(en)
*
|
2001-08-20 |
2003-10-23 |
Valkirs Gunars E. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US7524635B2
(en)
*
|
2003-04-17 |
2009-04-28 |
Biosite Incorporated |
Methods and compositions for measuring natriuretic peptides and uses thereof
|
US20040176914A1
(en)
*
|
2001-04-13 |
2004-09-09 |
Biosite Incorporated |
Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
|
US7713705B2
(en)
|
2002-12-24 |
2010-05-11 |
Biosite, Inc. |
Markers for differential diagnosis and methods of use thereof
|
US20030219734A1
(en)
*
|
2001-04-13 |
2003-11-27 |
Biosite Incorporated |
Polypeptides related to natriuretic peptides and methods of their identification and use
|
EP1666881B1
(en)
*
|
2001-05-04 |
2010-02-17 |
Biosite Incorporated |
Diagnostic markers of acute coronary syndromes and methods of use thereof
|
US20040209307A1
(en)
*
|
2001-08-20 |
2004-10-21 |
Biosite Incorporated |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US7608406B2
(en)
*
|
2001-08-20 |
2009-10-27 |
Biosite, Inc. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US20040219509A1
(en)
*
|
2001-08-20 |
2004-11-04 |
Biosite, Inc. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
CA2457775A1
(en)
*
|
2001-08-20 |
2003-02-27 |
Biosite Incorporated |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US6461828B1
(en)
|
2001-09-04 |
2002-10-08 |
Syn X Pharma |
Conjunctive analysis of biological marker expression for diagnosing organ failure
|
PT3072978T
(pt)
|
2002-05-09 |
2018-10-15 |
Brigham & Womens Hospital Inc |
1l1rl-1 como um marcador de doença cardiovascular
|
MXPA03004105A
(es)
*
|
2002-05-14 |
2004-10-15 |
Hoffmann La Roche |
Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores.
|
FR2843396B1
(fr)
*
|
2002-08-07 |
2005-04-15 |
Bio Rad Pasteur |
Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
|
AU2003302087A1
(en)
*
|
2002-11-18 |
2004-06-15 |
Syn X Pharma, Inc. |
Polyclonal-monoclonal elisa assay for detecting n-terminus probnp
|
US6960472B2
(en)
*
|
2002-11-18 |
2005-11-01 |
Ottawa Heart Institute Research Corporation |
Monoclonal antibodies against N-Terminus proBNP
|
US20040096919A1
(en)
|
2002-11-18 |
2004-05-20 |
Michelle Davey |
Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP
|
US20050287613A1
(en)
*
|
2002-11-18 |
2005-12-29 |
George Jackowski |
Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP
|
US7977072B2
(en)
*
|
2002-11-20 |
2011-07-12 |
B.R.A.H.M.S Gmbh |
Sandwich immunoassay for identifying partial proANP peptides
|
SG159387A1
(en)
|
2002-11-26 |
2010-03-30 |
Biocon Ltd In |
Modified natriuretic compounds, conjugates, and uses thereof
|
US7648962B2
(en)
*
|
2002-11-26 |
2010-01-19 |
Biocon Limited |
Natriuretic compounds, conjugates, and uses thereof
|
DE10316583A1
(de)
*
|
2003-04-10 |
2004-10-28 |
B.R.A.H.M.S Aktiengesellschaft |
Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
|
CA2522709A1
(en)
|
2003-04-17 |
2004-11-04 |
Ciphergen Biosystems, Inc. |
Polypeptides related to natriuretic peptides and methods of their identification and use
|
US20060177870A1
(en)
*
|
2003-04-28 |
2006-08-10 |
Ciphergen Biosystems, Inc |
Immunoassays
|
PL2256132T3
(pl)
|
2003-05-12 |
2016-08-31 |
Hoffmann La Roche |
Sposób wykrywania proBNP z zastosowaniem przeciwciała monoklonalnego
|
US20070037208A1
(en)
*
|
2003-05-29 |
2007-02-15 |
Foote Robert S |
Method for detecting cardiac ischemia via changes in b-natriuretic peptide levels
|
GB2403533A
(en)
|
2003-06-30 |
2005-01-05 |
Orion Corp |
Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof
|
JP2007502991A
(ja)
*
|
2003-08-20 |
2007-02-15 |
バイオサイト インコーポレイテッド |
生物活性ナトリウム利尿ペプチドを測定するための、およびその治療可能性を向上させるための方法および組成物
|
DE10351238A1
(de)
*
|
2003-11-03 |
2005-06-02 |
Roche Diagnostics Gmbh |
Diagnosestellung von akuten myokardialen, ischämischen Erkrankungen durch Kombination von Markern
|
DE10355731A1
(de)
|
2003-11-28 |
2005-06-30 |
Roche Diagnostics Gmbh |
Analytischer Sandwichtest zur Bestimmung von NT-proBNP
|
AT500800B1
(de)
|
2004-09-08 |
2008-07-15 |
Biomedica Medizinprodukte Gmbh |
Verfahren zur bestimmung von probnp
|
WO2007028070A2
(en)
*
|
2005-08-30 |
2007-03-08 |
Biosite, Inc. |
Use of soluble flt-1 and its fragments in cardiovascular conditions
|
EP1837659B1
(en)
|
2006-03-24 |
2010-06-09 |
F. Hoffman-la Roche AG |
Means and methods for the differentiation of acute and chronic myocardial necrosis in symptomatic patients
|
EP1845379A1
(en)
|
2006-04-13 |
2007-10-17 |
F. Hoffmann-La Roche AG |
Means and methods for the differentiation of cardiac and pulmonary causes of shortness of breath
|
ES2646142T3
(es)
|
2006-04-24 |
2017-12-12 |
Critical Care Diagnostics, Inc. |
Evaluación de la eficacia de un tratamiento en un sujeto en función de los niveles de ST2
|
WO2007143295A2
(en)
*
|
2006-04-27 |
2007-12-13 |
Critical Care Diagnostics, Inc. |
Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease
|
DK2021796T3
(da)
*
|
2006-05-01 |
2012-05-29 |
Critical Care Diagnostics Inc |
Diagnose af hjerte-kar-sygdom
|
DK2019965T3
(en)
*
|
2006-05-02 |
2015-07-20 |
Critical Care Diagnostics Inc |
DIFFERENTIAL BETWEEN LUNG AND Cardiovascular Disease
|
US8147817B2
(en)
*
|
2006-05-04 |
2012-04-03 |
The Brigham And Women's Hospital, Inc. |
IL-33 in the treatment and diagnosis of diseases and disorders
|
EP1882945A1
(en)
|
2006-07-28 |
2008-01-30 |
F.Hoffmann-La Roche Ag |
Means and methods for the differentiation of cardiac and pulmonary causes of acute shortness of breath
|
KR101245877B1
(ko)
|
2006-08-04 |
2013-03-20 |
메디치니쉐 호흐슐레 하노버 |
Gdf-15 를 바탕으로 한, 심장 중재의 위험도를 평가하는수단 및 방법
|
EP1890153A1
(en)
|
2006-08-16 |
2008-02-20 |
F. Hoffman-la Roche AG |
Cardiac troponin as an indicator of advanced coronary artery disease
|
ATE449966T1
(de)
|
2006-09-15 |
2009-12-15 |
Hoffmann La Roche |
Biochemische marker für akute lungenembolie
|
EP1925943A1
(en)
|
2006-11-21 |
2008-05-28 |
F. Hoffman-la Roche AG |
Means and methods for optimization of diagnostic and therapeutic approaches in chronic artery disease based on the detection of Troponin T and NT-proBNP.
|
EP2089719A2
(en)
*
|
2006-11-21 |
2009-08-19 |
Roche Diagnostics GmbH |
Means and methods for optimization of diagnostic and therapeutic approaches in chronic artery disease based on troponin t and nt-probnp
|
ES2430290T3
(es)
*
|
2007-03-06 |
2013-11-19 |
F. Hoffmann-La Roche Ag |
Utilización de péptidos de tipo PNC para predecir la necesidad de diálisis
|
AT504942B1
(de)
|
2007-03-07 |
2009-08-15 |
Biomedica Medizinprodukte Gmbh |
Verfahren zur bestimmung von probnp
|
EP2031397A1
(en)
|
2007-08-30 |
2009-03-04 |
F. Hoffmann-La Roche AG |
Surfactant proteins B and D in differentiating the causes of shortness of breath
|
EP2210111A1
(en)
|
2007-10-10 |
2010-07-28 |
Roche Diagnostics GmbH |
Natriuretic peptide/troponin ratio for the assessment of preexisting myocardial dysfunction in patients with acute coronary syndrome
|
US9482677B2
(en)
|
2008-02-27 |
2016-11-01 |
Scios Inc. |
Method, composition and device for sampling natriuretic peptides in a biological fluid
|
SI2827152T1
(sl)
|
2008-04-18 |
2016-10-28 |
Critical Care Diagnostics,Inc. |
Napovedovanje tveganja večjih neželenih srčno-žilnih dogodkov
|
US20090286329A1
(en)
*
|
2008-05-19 |
2009-11-19 |
Abbott Laboratoires |
Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
|
US20090286256A1
(en)
*
|
2008-05-19 |
2009-11-19 |
Abbott Laboratories |
Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
|
EP2294424A1
(en)
|
2008-05-21 |
2011-03-16 |
F. Hoffmann-La Roche AG |
L-fabp, natriuretic peptides and cardiac troponin in individuals in need for a cardiac therapy
|
ES2644723T3
(es)
|
2008-07-23 |
2017-11-30 |
F. Hoffmann-La Roche Ag |
Identificación de sujetos susceptibles de tratamiento antiangiogénico
|
CA2732201A1
(en)
|
2008-08-13 |
2010-02-18 |
F. Hoffmann-La Roche Ag |
D-dimer, troponin, nt-probnp for pulmonary embolism
|
US20100297607A1
(en)
|
2009-05-20 |
2010-11-25 |
Jian Zheng |
Reagents For HCV Antigen-Antibody Combination Assays
|
KR101522078B1
(ko)
|
2009-09-17 |
2015-05-20 |
에프. 호프만-라 로슈 아게 |
좌심실 비대에 대한 멀티마커 패널
|
BR112012011230A2
(pt)
*
|
2009-11-13 |
2016-04-05 |
Bg Medicine Inc |
fatores de risco e previsão de infarto do miocárdio
|
ES2647461T3
(es)
|
2009-12-18 |
2017-12-21 |
F. Hoffmann-La Roche Ag |
GDF-15 y/o troponina T para predecir insuficiencia renal en pacientes con cirugía cardíaca
|
WO2011098519A1
(en)
|
2010-02-12 |
2011-08-18 |
Synlab Medizinisches Versorgungszentrum Heidelberg Gmbh |
Homoarginine as a biomarker for the risk of mortality
|
EP2388594A1
(en)
|
2010-05-17 |
2011-11-23 |
Roche Diagnostics GmbH |
GDF-15 based means and methods for survival and recovery prediction in acute inflammation
|
EP2601531A1
(en)
|
2010-08-04 |
2013-06-12 |
IDEXX Laboratories, Inc. |
Detection of degradation products of canine nt-probnp
|
WO2012020045A1
(en)
|
2010-08-10 |
2012-02-16 |
Roche Diagnostics Gmbh |
Method for selecting patients with stable coronary artery disease for pci or medical treatment
|
EP2367006A1
(en)
|
2010-08-24 |
2011-09-21 |
Roche Diagnostics GmbH |
PLGF-based means and methods for diagnosing cardiac causes in acute inflammation
|
ES2627337T3
(es)
|
2010-08-26 |
2017-07-27 |
F. Hoffmann-La Roche Ag |
Uso de biomarcadores para controlar una medicación en un sujeto que padece insuficiencia cardíaca
|
EP2439535A1
(en)
|
2010-10-07 |
2012-04-11 |
F. Hoffmann-La Roche AG |
Diagnosis of diabetes related heart disease and GDF-15 and Troponin as predictors for the development of type 2 diabetes mellitus
|
EP2447720A1
(en)
|
2010-10-26 |
2012-05-02 |
Roche Diagnostics GmbH |
sFlt1 and pulmonary complications
|
EP2383579A1
(en)
|
2010-12-17 |
2011-11-02 |
F. Hoffmann-La Roche AG |
sFlt-1, cardiac troponins and natriuretic peptides in the recognition of therapy with HER-2 inhibitors
|
US8728742B2
(en)
|
2011-03-17 |
2014-05-20 |
Critical Care Diagnostics, Inc. |
Methods predicting risk of an adverse clinical outcome
|
EP2715353B1
(en)
|
2011-05-31 |
2016-08-24 |
IDEXX Laboratories, Inc. |
DETECTION OF DEGRADATION PRODUCTS OF FELINE NT-proBNP
|
EP2385373A1
(en)
|
2011-07-01 |
2011-11-09 |
F. Hoffmann-La Roche AG |
Natriuretic peptides in pregnancy
|
EP2581040A1
(en)
|
2011-10-10 |
2013-04-17 |
Roche Diagnostics GmbH |
TnT based cardiac hypertrophy risk related physiological training and guidance in athletes
|
BR122021026652B1
(pt)
|
2011-10-17 |
2022-08-23 |
F. Hoffmann-La Roche Ag |
Método in vitro para diagnosticar fibrilação atrial intermitente, uso de uma troponina cardíaca e dispositivo para diagnosticar fibrilação atrial intermitente
|
WO2013079567A2
(en)
|
2011-12-01 |
2013-06-06 |
Roche Diagnostics Gmbh |
Nt-proanp and nt-probnp for the diagnosis of stroke
|
ES2538226T3
(es)
|
2012-01-26 |
2015-06-18 |
F. Hoffmann-La Roche Ag |
Método para la diferenciación de la insuficiencia cardiaca anterógrada y retrógrada
|
EP2650684A1
(en)
|
2012-04-10 |
2013-10-16 |
Roche Diagniostics GmbH |
Pro SP-B and NT-proBNP based diagnosis in patients with pneumonia
|
EP2615459A1
(en)
|
2012-04-27 |
2013-07-17 |
Roche Diagniostics GmbH |
proSP-B based diagnosis of distal airway involvement in asthma
|
EP2600155A1
(en)
|
2012-06-18 |
2013-06-05 |
Roche Diagniostics GmbH |
sFlt-1 based diagnosis and monitoring of stroke patients
|
EP2597467A1
(en)
|
2012-06-26 |
2013-05-29 |
Roche Diagniostics GmbH |
Means and methods for proSP-B based diagnosis of pulmonary congestion in ACS patients
|
EP2597466A1
(en)
|
2012-06-26 |
2013-05-29 |
Roche Diagniostics GmbH |
Means and methods for proSP-B based diagnosis of alveolar damage in pulmonary hypertension patients
|
WO2014009418A1
(en)
|
2012-07-10 |
2014-01-16 |
Roche Diagnostics Gmbh |
TnT, NTproBNP, sFlt-1 for CURB65 IN PNEUMONIA
|
RU2015110054A
(ru)
|
2012-08-21 |
2016-10-10 |
Критикал Кэа Дайэгностикс, Инк. |
Мультимаркерная стратификация риска
|
EP2895866B1
(en)
|
2012-09-12 |
2018-05-30 |
Roche Diagnostics GmbH |
Identification of patients with abnormal fractional shortening
|
US20140273273A1
(en)
|
2012-11-01 |
2014-09-18 |
Christie Mitchell Ballantyne |
Biomarkers to improve prediction of heart failure risk
|
EP2730923A1
(en)
|
2012-11-09 |
2014-05-14 |
Roche Diagniostics GmbH |
NTproBNP and cTnT based therapy guidance in heart failure
|
CN108120837B
(zh)
|
2012-11-09 |
2021-06-22 |
霍夫曼-拉罗奇有限公司 |
阵发性心房纤颤的基于TnT的诊断
|
EP2929354B1
(en)
|
2012-12-04 |
2018-04-18 |
Roche Diagnostics GmbH |
Biomarkers in the selection of therapy of heart failure
|
US9862773B2
(en)
*
|
2013-03-15 |
2018-01-09 |
The Translational Genomics Research Institute |
Hybridoma clones and monoclonal antibodies to CD9
|
JP6159010B2
(ja)
*
|
2013-03-15 |
2017-07-05 |
ザ・トランスレーショナル・ジェノミクス・リサーチ・インスティチュート |
テトラスパニン8に対するハイブリドーマクローンおよびモノクローナル抗体
|
EP2866033A1
(en)
|
2013-10-23 |
2015-04-29 |
Roche Diagniostics GmbH |
Differential diagnosis of acute dyspnea based on C-terminal proSP-B, KL-6 and BNP-type peptides
|
AU2014343709B2
(en)
|
2013-11-04 |
2020-11-19 |
The Regents Of The University Of Michigan |
Biomarkers and methods for progression prediction for chronic kidney disease
|
ES2712201T3
(es)
|
2014-01-28 |
2019-05-09 |
Hoffmann La Roche |
Biomarcadores para la evaluación de riesgos y la monitorización del tratamiento en pacientes de insuficiencia cardíaca que han recibido terapia guiada por el péptido natriurético de tipo B
|
EP2916134B1
(en)
|
2014-03-05 |
2017-08-16 |
Roche Diagnostics GmbH |
Use of Seprase for differential diagnosis of acute dyspnea
|
ES2939018T3
(es)
|
2014-03-26 |
2023-04-18 |
Hoffmann La Roche |
IGFBP7 para diagnosticar una disfunción diastólica
|
EP3279665B1
(en)
|
2016-08-04 |
2020-07-08 |
Roche Diagniostics GmbH |
Circulating esm-1 (endocan) in the assessment of atrial fibrillation
|
WO2018069487A1
(en)
|
2016-10-14 |
2018-04-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and kits for predicting the risk of loss of renal function in patients with type 2 diabetes
|
WO2018127372A1
(en)
|
2016-12-13 |
2018-07-12 |
Witteman Johanna Cornelia Maria |
Detection of transient troponin peaks for diagnosis of subjects at high risk of cardiovascular disease
|
CN113167799A
(zh)
|
2018-07-31 |
2021-07-23 |
豪夫迈·罗氏有限公司 |
循环DKK3(Dickkopf相关蛋白3)在心房颤动评定中的应用
|
KR20210044216A
(ko)
|
2018-08-10 |
2021-04-22 |
에프. 호프만-라 로슈 아게 |
심방세동-관련 뇌졸중 평가를 위한 ces-2 (카르복실에스테라제-2)
|
JP2021535370A
(ja)
|
2018-08-16 |
2021-12-16 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
心房細動および抗凝固療法の評価における循環tfpi−2(組織因子経路阻害剤2)
|
CN113260863A
(zh)
|
2018-08-17 |
2021-08-13 |
豪夫迈·罗氏有限公司 |
用于心房纤颤的评价中的循环bmp10 (骨形态发生蛋白10)
|
EP3841381A1
(en)
|
2018-08-22 |
2021-06-30 |
Roche Diagnostics GmbH |
Circulating spon-1 (spondin-1) in the assessment of atrial fibrillation
|
WO2020039085A1
(en)
|
2018-08-24 |
2020-02-27 |
Roche Diagnostics Gmbh |
Circulating fgfbp-1 (fibroblast growth factor-binding protein 1) in the assessment of atrial fibrillation and for the prediction of stroke
|
WO2020064995A1
(en)
|
2018-09-28 |
2020-04-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of biomarkers representing cardiac, vascular and inflammatory pathways for the prediction of acute kidney injury in patients with type 2 diabetes
|
WO2020234451A1
(en)
|
2019-05-23 |
2020-11-26 |
Roche Diagnostics Gmbh |
IGFBP7 RATIO FOR HFpEF
|
CN115190886A
(zh)
|
2020-02-20 |
2022-10-14 |
马斯特里赫特大学 |
循环bmp10(骨形态发生蛋白10)的检测方法
|
EP4365598A1
(en)
|
2022-11-07 |
2024-05-08 |
Hôpitaux Universitaires Saint-Louis-Lariboisière |
Rapid optimization of oral heart failure therapies helped by nt-probnp testing
|
WO2024100050A1
(en)
|
2022-11-07 |
2024-05-16 |
Hôpitaux Universitaires Saint-Louis-Lariboisière |
Rapid optimization of oral heart failure therapies helped by nt-probnp testing
|